USSTOCK.TODAY
Market Closed
Log in Sign up

Axsome Therapeutics Inc. Third Quarter Results Beat Wall Street Estimates

Associated Press · ·by G4L

AXSM
AXSM Axsome Therapeutics Inc
$140.97 +5.23%
View chart & analysis →
  1. 1Axsome Therapeutics Inc. reported a loss of $12.9 million for the third quarter.
  2. 2Axsome Therapeutics Inc.'s third-quarter loss per share of $0.25 exceeded Wall Street estimates.
  3. 3Axsome Therapeutics Inc.'s revenue of $259.7 million for the period surpassed the $246.4 million revenue estimate from 7 analysts surveyed by Zacks.

So what's the key point?

Axsome Therapeutics Inc. reported smaller losses than expected in the third quarter. This means the company's performance was better than anticipated because revenue was higher than what experts predicted.

Source Associated Press · View original ↗

Related 3-line summaries

Caitlin Clark signs multi-year deal with Dick's Sporting Goods and Foot Locker CNBC +3 · 6d agoAxsome Therapeutics Reports Third Quarter Results Exceeding Expectations Earnings Whispers · Nov 2Axsome Therapeutics records 29.06% CAGR over the past 5 years The Motley Fool · Oct 30
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news